Tvardi Therapeutics Climbs 2.27% Amid Volatile Biotech Market, Holding $1.02 Price
Tvardi Therapeutics sees a modest 2.27% rally amid biotech volatility, holding above its 200‑day SMA while awaiting clinical milestones.
- TVARDI THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read